SELLAS Life Sciences Group Inc宣布,思路迪医药股份(3D Medicines)将继续推进Galinpepimut-S在大中华区的开发与商业化工作。
SELLAS Life Sciences Group Inc宣布,思路迪医药股份(3D Medicines)将继续推进Galinpepimut-S在大中华区的开发与商业化工作。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.